Hyping of meningitis ‘outbreak' a big score for Big Pharma

How many kids will become guinea pigs for this unapproved new vaccine?

When the CDC shouts “outbreak,” you better run for cover.

Who knows what’s next? Maybe hazmat-suited doctors will be walking the streets keeping us quarantined at gunpoint (or should Dustin Hoffman be brought in to save the day)?

What’s happening now in New Jersey and California is even worse than a fast-track drug approval.

And only one group is smiling as a result of this media-hyped “outbreak” scare…the CDCs drug-making friends at Novartis.

Our story begins with an unapproved drug getting rushed in from Europe under the hysteria of a supposed “epidemic.”

It continues with thousands of college students forced into lives as guinea pigs.

And the horrors don’t end there…

Not so fast…

One thing we know for sure is that Novartis is going to come out ahead on this one.

It was a real blow to the drug company last July when the UK rejected its Bexsero vaccine for meningitis B. It was hoping that this new drug, which it had been tinkering with for 15 years, would rescue its sinking vaccine business.

In its thumbs-down vote for Bexsero, the UK committee on vaccinations said that the data was “too limited” to “identify rare reactions to the vaccine.”

And as is all too typical on this side of the pond, they said the company didn’t provide adequate proof that it even works.

So was the party over for Novartis and Bexsero? Not by a long shot.

Thanks to the CDC, there was a real outbreak in December. An outbreak of media hysteria about meningitis B at two universities.

And that has put out a big welcome mat for Bexsero right here in the U.S. It’s an epidemic, all right, and Big Pharma is going to save us.

So if you’re the parent or grandparent of a college kid, here’s a dose of reality on this from vaccine expert, Dr. Sherri Tenpenny.

First, this is not an epidemic. There were only seven cases of meningitis B over nine months when the CDC started hysterically screaming “outbreak.”
Meningitis is not spread through the air — you cannot catch it by casual contact.
It occurs “randomly” and doesn’t “spread rapidly across the campus.”
Making a vaccine for the B strain is risky, so Novartis had to find a “work-around” to come up with something that wouldn’t cause vaccine-induced antibodies to attack the brain.
The CDC, helped along by the media, are “terrorizing” people into getting this vaccine.
The CDC has mysteriously changed its “risk” figures for how many kids living in a dorm might get the disease. Tenpenny says this was done to make a “market share” for the vaccine. And…
Like everything else in the drug business “it’s all about the money.”

To stay healthy in college — and avoid a “potentially neurotoxic vaccine” — Dr. Tenpenny advises students to get more sleep, eat better, open the window for some fresh air, not share things that touch the mouth and nose, and, of course, wash their hands more often.

All of which are better, she says, than getting “an unproven vaccine with possibly serious, long term autoimmune consequences.”

Seems like Dr. Tenpenny is giving Novartis an F for its college work…

Sources:
“Using an Unapproved Meningitis Vaccine? — Not So Fast” Dr. Sherri Tenpenny, DO, AOBNMM, ABIHM,” tenpennyimc.com